Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston May 26, 2023 6:08am
315 Views
Post# 35465241

RE:Listening to a genius...(TLT best move).

RE:Listening to a genius...(TLT best move).

Great post Wildbird1.

Roger did take the time to listen, even when the molecule of Dr. McFarland was just a concept. And 13y later, Theralase is still the only one pushing PDT/PDC.  Nobody else ever come close to jump in, like we did.


____________

 

Listening to a genius...(TLT best move).
Before criticizing R.Dumoulin-White or TLT management, think about the fact that it was DrMcFarland that contacted TLT, in order to ask for help to prove her theory that Light could cure cancer.
R.Dumoulin took the time to listen to that genius(DrMcfarland), and understood that her light activated compound was something very very big.

R.Dumoulin-White started with nothing and now we are on the verge of BTD and or AA approval.

And TLT did it with only 313 million shares outstanding, which is a puny little number of shares if you consider that TLT is aiming at multiple cancer treatments(NMIBC,GBM,NSCLC) etc...

We all know that the SP is at .23$ for now, big deal......

I don't understand the posters that constantly throw dirt on TLT management.

TLT management deserve our appreciation for the heavy work they did, with so little money available.
<< Previous
Bullboard Posts
Next >>